Follow-up of blood donors positive for HCV serology and of their recipients is insufficient;Le suivi des donneurs de sang ayant une serologie du virus de l'hepatite C positive et de leurs receveurs est insuffisant

Gastroenterologie Clinique et Biologique

Volumn 20, Issue 8-9, 1996, Pages 663-668

  Bonaguidi Magniaux, Mireille ^a   Pilette, Christophe ^a   Oberti, Frédéric ^a   Bidet, Marie Laure ^a   Calés, Paul ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

ALT; anti HBc antibodies; blood donors; hepatitis C virus; RIBA test; screening; transfusion

Indexed keywords

ANTIBODY DETECTION; ARTICLE; BLOOD TRANSFUSION; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; FRANCE; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; SCREENING TEST; VIRUS DETECTION;

BLOOD DONORS; BLOOD TRANSFUSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOBLOTTING; MALE; SEROLOGIC TESTS;

EID: 0029770097     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Colombo M, Oldani S, Donato MF, Borzio M, Santese R, Roffi L, et al. A multicenter, prospective study of post-transfusion hepatitis in Milan. Hepatology 1987;7:702-12.
2. Feinman SV, Berris B, Bojarski S. Post-transfusion hepatitis in Toronto, Canada. Gastroenterology 1988;95:464-9.
3. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321: 1494-500.
4. Koziol DE, Holland PV, Alling DW, Melpolder JC, Solomon RE, Purcell RH, et al. Antibody to hepatitis B core antigen as a paradoxal marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986;104;488-95.
5. Morgan C, Hyland C, Young IF. Hepatitis C antibody and transaminase activity in blood donors. Lancet 1990;1:921.
6. Jullien AM, Couroucé AM, Massari V, Maniez M, Finetti P, Breviere D, et al. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. Eur J Clin Microbiol Infect Dis 1993;12:668-72.
7. Japanese Red Cross non-A, non-B Hepatitis Research Group. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 1991;338:1040-1.
8. Gonzalez A, Esteban JI, Madoz P, Viladomiu L, Genesca J, Muniz E, et al. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial. Hepatology 1995;22: 439-45.
9. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
10. Trépo C, Bizollon T. Limites de la sérologie du virus de l'hépatite C. Gastroenterol Clin Biol 1992;16:495-7.
11. Mathiesen UL, Karlsson E, Foberg U, Fryden A, Franzen L, Widell A, et al. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery. Scand J Gastroenterol 1993;28:581-4.
12. Kolho E, Naukkarinen R, Krusius T. Transmission of HCV infection by RIBA indeterminate and positive blood units. Transfus Med 1992;2:243-8.
13. Kleinman S, Alter H, Bush M, Holland P, Tegtmieier G, Nelles M, et al. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992;32:805-13.
14. Vallari DS, Jett BW, Alter HJ, Mimms LT, Holzman R, Shih JW. Serological markers of post-transfusion hepatitis C viral infection. J Clin Microbiol 1992;30:552-6.
15. Alter MJ. The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 1993;2:155-66.
16. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995;15:5-14.
17. Tobler LH, Busch MP, Wilber J, Dinello R, Quan S, Polito A, et al. Evaluation of indeterminate C22-3 reactivity in volunteer blood donors. Transfusion 1994;34:130-4.
18. Van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-9.
19. Alter MJ. Review of serologic testing for hepatitis C virus infection and risk of post-transfusion hepatitis C. Arch Pathol Lab Med 1994;118:342-5.
20. Serfaty L, Giral P, Elghouzzi MH, Jullien AM, Poupon R. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey. Hepatology 1993;17:183-7.
21. Skidmare S. Recombinant immunoblot assay for hepatitis C antibody. Lancet 1990;335:1346.
22. Zaaijer HL, Cuypers HTM, Reesink HW, Lelie PN. New immunoblot resolves indeterminates results for antibody to hepatitis C virus. Transfusion 1994;34:184.
23. MacDonald KL, Mills WA, Wood RC, Hanson M, Kline W, Bowman RJ, et al. Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population. Transfusion 1994;34:202-8.
24. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Ranes A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.
25. Centers for Disease Control. Public health service inter-agency guidelines for screening donors of blood, plasma, organs, tissues and semen for evidence of hepatitis B and hepatitis C. MMWR 1991;40:1-17.
26. Serfaty L, Nousbaum JB, Elghouzzi MH, Giral P, Legendre C, Poupon R. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test. Hepatology 1995;21:725-9.
27. Zanella A, Conte D, Prati D, Mozzi F, Capelli C, Zanuso F, et al. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay. Hepatology 1995;21:913-7.
28. Watanabe M, Ohkoshi S, Tawaraya H, Miyajima T, Shimotohno K, Kamimura T, et al. Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission. Transfusion 1994;34:125-9.
29. Mazda T, Nakata K, Bannai M, Miyamura T, Chiba J, Ohba H, et al. Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis. Transfus Med 1993;3:149-51.
30. Trépo C, Opolon P, Janot C, Boudart D, Cotte C, Couroucé AM, et al. Attitude pratique devant la découverte de marqueurs sériques d'infection par le virus de l'hépatite B (Ag HBs et/ou Ac anti HBc), une hypertransaminasémie ou les 2 anomalies chez un donneur de sang. Rev Fr Transfus Hemobiol 1991:34:285-94.
31. Blajchman MA, Bull SB, Feinman SV. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Lancet 1995;345:21-5.
32. Shimoyama R, Sekigushi S, Suga M, Sakamoto S, Yachi A. The epidemiology and infection route of asymptomatic HCV carriers detected through blood donations. Gastroenterol Jpn 1993;28(suppl. 5):1-5.
33. McCaughan GW, McGuinness PH, Bishop GA, Painter DM, Lien AS, Tulloch R, et al. Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors. Med J Aust 1992;157:231-3.
34. Esteban JI, Lopez-Talavera JC, Genesca J, Madoz P, Viladomiu L, Muniz E, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991;115:443-9.
35. Alberti A, Chemello L, Cavalletto D, Tagger A, Dal Canto A, Bizzaro N, et al. Antibody to hepatitis C virus and liver disease in volonteer blood donors. Ann Intern Med 1991;114:1010-2.
36. Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontinor P, et al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992;340: 697-8.
37. Ryan KE, MacLennan S, Barbara JAJ, Hewitt PE. Follow up of blood donors positive for antibodies to hepatitis C virus. BMJ 1994;308:696-7.
38. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuch T, Kiramura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-801.
39. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 2:671-5.
40. Romeo JM, Ulrich PP, Busch MP, Vyas GN. Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors. Hepatology 1993;17:188-95.